肾动脉狭窄高血压患者:血管内治疗与药物治疗的系统评价更新
该系统评价沿用2014年Cochrane综述的方法并扩展至2014至2018年文献,纳入的随机对照试验显示球囊血管成形术(联合或不联合支架)相比药物治疗未显示显著获益,试验间无显著异质性,建议对更严重肾动脉狭窄患者进一步研究。
要点
- 球囊血管成形术联合或不联合支架相比药物治疗未显示显著改善。
- 纳入试验间无显著异质性。
- 建议对更严重肾动脉狭窄患者进一步研究。
核心结论
- 球囊血管成形术联合或不联合支架相比药物治疗未显示显著改善。
研究设计与样本
- 系统评价与荟萃分析,沿用2014年Cochrane综述方法并扩展纳入2014至2018年文献。
主要发现
- 荟萃分析显示试验间无显著异质性。
- 球囊血管成形术联合或不联合支架相比药物治疗未显示显著改善。
临床怎么用
- 对于肾动脉狭窄高血压患者,血管内治疗相比药物治疗未显示显著获益,决策需个体化。
局限性
- 两项持续进行的试验尚未发表结果。
- 需进一步研究评估更严重肾动脉狭窄患者的获益。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The benefit of balloon angioplasty, with or without stenting, for the treatment of patients with renal artery stenosis remains controversial. A number of randomized controlled trials have attempted to determine its efficacy but the matter remains unclear. A 2014 Cochrane review, which combined data from 8 trials, showed homogeneity among the trials with no significant benefit shown. This systematic review replicates the same research methods and meta-analysis while expanding it to include papers between 2014 and 2018. One of the trials included in the previous review published results in the interim. Additionally, 2 ongoing trials identified in the 2014 review are yet to publish any result. Meta-analysis of the reports showed no heterogeneity between trials and no significant improvement shown by balloon angioplasty, with or without stenting, versus medical therapy. Further studies are recommended in order to assess the benefits of balloon angioplasty for patients with more severe renal artery stenosis.
引用
- Piaggio D, Bracale U, Pecchia L, et al. Endovascular Treatment versus Medical Therapy for Hypertensive Patients with Renal Artery Stenosis: An Updated Systematic Review. Ann Vasc Surg. 2019. PMID: 31376542. doi:10.1016/j.avsg.2019.04.050
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。